Published in Curr Opin Mol Ther on April 01, 2001
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A (2003) 2.05
Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res (2004) 1.89
Fluorescent probes for live-cell RNA detection. Annu Rev Biomed Eng (2009) 1.59
Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem (2007) 1.58
Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci (2009) 1.31
A novel inhibitor of N-ethylmaleimide-sensitive factor decreases leukocyte trafficking and peritonitis. J Pharmacol Exp Ther (2005) 1.14
Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther (2009) 1.11
Advances in Systemic siRNA Delivery. Drugs Future (2009) 0.87
Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Mol Pharm (2011) 0.86
Molecular beacons: powerful tools for imaging RNA in living cells. J Nucleic Acids (2011) 0.85
Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice. Curr HIV Res (2015) 0.83
NANOSTRUCTURED PROBES FOR IN VIVO GENE DETECTION. Nanomedicine (Chichester) (2010) 0.78
Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides. Pharmaceuticals (Basel) (2010) 0.77
The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates. PLoS One (2014) 0.75
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
TAT-mediated protein transduction into mammalian cells. Methods (2001) 2.64
Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res (2001) 2.54
Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol (1997) 2.40
Protein transduction: unrestricted delivery into all cells? Trends Cell Biol (2000) 2.37
In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci (2000) 2.35
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature (2000) 2.10
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78
Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem (2000) 1.69
The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci (1992) 1.68
Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci U S A (1997) 1.67
Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med (1999) 1.63
Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques (2001) 1.57
Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res (1999) 1.38
Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res (2001) 1.33
p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep (2001) 1.20
Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death. Methods Enzymol (2000) 1.16
Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc Natl Acad Sci U S A (1999) 1.09
TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J Biol Chem (2001) 1.08
Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation (1986) 1.06
TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point. Immunity (1998) 1.03
Apoptin/VP3 contains a concentration-dependent nuclear localization signal (NLS), not a tumorigenic selective NLS. J Virol (2004) 0.98
Protein transduction: delivery of Tat-GTPase fusion proteins into mammalian cells. Methods Enzymol (2001) 0.95
Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol (2001) 0.91
Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins. Oncogene (1991) 0.85
Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Hum Mol Genet (1996) 0.85
p73. Int J Biochem Cell Biol (2001) 0.85
Modulation of retinoblastoma protein activity during the cell cycle. Cold Spring Harb Symp Quant Biol (1991) 0.83
Antitumour effects of PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells. Br J Cancer (2004) 0.82
Expression, purification, and functional characterization of adenovirus 5 and 12 E1A proteins produced in insect cells. Virology (1992) 0.81
The cancer cell and the cell cycle clock. Cold Spring Harb Symp Quant Biol (1994) 0.80
Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand. Int Immunol (1998) 0.78
Enhanced kidney graft survival in rats by single or multiple blood transfusion(s) and various blood products. Transplant Proc (1982) 0.76
2-D phosphopeptide mapping. Methods Mol Biol (1999) 0.76
Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation. Transplant Proc (1987) 0.75
Decreased reactivity of allosera against target lymphocytes obtained following thermal injury or long-term cyclosporine treatment. Clin Immunol Immunopathol (1987) 0.75
Serologic properties of the triple antibody-sandwich-lymphocyte-agglutination assay (TASLA). J Clin Lab Immunol (1989) 0.75
Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant. Transplantation (1987) 0.75